Syneos Health Partners with Medable to Expand Decentralized Solutions
Syneos Health and Medable have announced a partnership to deliver decentralized capabilities to Syneos Health with the aim of increasing clinical trial diversity, while also aiming to improving patient access and experiences.
Syneos Health will gain access to Medable’s digital platform as well as deliver a decentralized digital solution to Syneos Health customers tailored to the specific attributes and requirements for conducting non-interventional research.
Medable will also now be part of the Syneos Health Dynamic Assembly network, an open ecosystem of data and technology collaborators committed to delivering solutions designed to strategically address the nuances of each customer engagement.
For more information, click here.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
